SBIR/STTR Research Award
Rapid, Automated, Multiplexed Omics Platform
Award amount
$249,994Program and phase
SBIR · Phase IAward year
2025Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- EMERGINGDX INC
- Proposal award date
- 2024-10-08
- Contract end date
- 2025-05-08
- UEI
- C1LMYC2AY934
- Solicitation number
- 24.2
- Topic code
- DHA242-001
Research abstract
EmergingDx Inc in collaboration with academic and industrial partners will develop an automated, portable, rapid, highly multiplexed diagnostic platform for identification and quantification of multi-omics for sepsis from a minimally invasive biomatrix. The platform will be flexible to adapt new omics on demand, as well as suitable to accept minimally invasive clinical samples, such as urine and saliva besides blood.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Autonomous Soft Robot for Locomotion in Granular Seabed Media
- Rapid, Automated, Multiplexed Omics Platform
- Integrated Multiplexed Low-Cost Diagnostic Platform for Rapid Microbial Identification
- Multiplexed Diagnostic Platform for Invasive Fungal Infection
- Automated Detection Platform of Circulating and Exosomal miRNAs
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- RapiOmics-Plex: A Platform for Rapid Detection of Highly-Multiplexed Multi-omics Biomarker Panel
- Innovative DNA for Highly Multiplexed Molecular Diagnostics
- Development of a Wide Multiplexing, Multifunctional Platform for Flexible Diagnostics
- RapiOmics-Plex: A Platform for Rapid Detection of Highly Multiplexed Multi-omics Biomarker Panel
Research funding history
12 SBIR/STTR records share this UEI (2023–2025). Reported award amounts total $6,696,877. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Agriculture